miRNA-150 inhibits hCD133+ liver CSCs through negative regulation of c-Myb

BioMan

MicroRNA-150 inhibits human CD133-positive liver CSCs through negative regulation of the TF c-Myb.
3 \1 j  ~7 D1 v% i/ v/ U- q4 k  Z; G7 ]7 O, o. j* G
MicroRNAs (miRNAs) have been implicated in the maintenance of the cancer stem cell (CSC) phenotype via their ability to affect expression of genes and proteins that regulate cell proliferation and/or cell death. Thus, identification of CSC-related miRNAs would provide information for a better understanding of CSCs. Here, we compared the miRNA profiles of CD133+ and CD133- primary hepatocellular carcinoma (HCC) subpopulations and found upregulation of 5 miRNAs in CD133- subpopulations, including hsa-miR-150, which may be involved in maintenance of the CD133+ liver CSC phenotype. We also show that miR-150 interacts with the 3'UTR of c-Myb mRNA and overexpression of miR-150 downregulates c-Myb protein levels. Furthermore, overexpression of miR-150 lead to a significant reduction of CD133+ cells, accompanied by significant inhibition of cell growth and tumorsphere formation. In addition, overexpression of miR-150 induces cell cycle arrest and apoptosis in CD133+ cells. Consistent with the outcome of cell cycle arrest and cell apoptosis, Western blotting results demonstrate that the cell cycle regulator cyclin D1 and cell survival regulator Bcl-2 are decreased in cells transfected with miR-150. Collectively, our findings demonstrate for the first time that miR-150 may be involved in liver CSC self-renewal, potentially via modulation of the downstream target c-Myb.
8 W) }) T( R  L. a3 {8 ]# r+ `( y: y; M( v4 {5 `
http://www.ncbi.nlm.nih.gov/pubmed/22025269?dopt=Abstract

zhangjinami

很有意思的文章
# s; M, ^; x1 h6 amicroRNA 可以通过抑制mrna以及蛋白质发挥作用6 v; s) [  `7 x! e( D
micro能不能抑制lncRNA的表达